gastroenterology
Medicines

Biosimilar naming convention still under review

The TGA says it is continuing to discuss the adoption of a naming convention for biosimilars with other overseas regulators. The revelation comes following the release of a communiqué from the August meeting of the Biosimilar Awareness Initiative Reference Group, which was set up to “give guidance on the activities of the Biosimilar Awareness Initiative ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic